Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Synthetic Biology
Gene Expression
Genotyping
qPCR
Sequencing
Single-cell Genomics

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
POD™ Automation Platform
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime™ Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications and Articles
Application Notes
Posters
Webinars
Videos
Customer Profiles

Support

Brochures
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Integration Models
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Careers
Contact and Location
Privacy Policy
ADME-Tox | Labcyte Inc.

ADME-TOX

Reduce reaction volumes and increase throughput

HOME | APPLICATIONS | ADME-Tox

Enable Cost-Effective, Earlier Safety Screening

During drug development, ADME characterization is critical to measuring the kinetics of drug exposure and overall performance and toxicity within an organism. It is traditionally used during the later stages of lead optimization. Increasingly, though, research organizations are demanding earlier ADME-Tox studies to reduce late-phase drug failures and the associated costs.

Ensure your drug candidates are well characterized and development costs are minimized

ADME Tox

Significantly Improved Characterization

Characterizationon of Absorption, Distribution, Metabolism, and Excretion (ADME) and Toxicity drug profiles are a critical step in drug development. Due to the expense of drug candidates failing into clinical trials, it is key to accurately determine drug characteristics earlier, and ideally in a cost effective manner. Using the Echo liquid handler, researchers are successfully implementing comprehensive ADME-Tox screens during the early stages of drug discovery, helping to ensure that drug candidates are well characterized and development costs are minimized. The low transfer volume increments of the Echo liquid handler products enables total volume miniaturization without sacrificing data quality. Non-contact transfer of drug candidates ensures that interferences from traditional liquid handling techniques (such as hydrophobic interactions with plastic tips) are minimized.

Key Benefits

  • Reduced reaction volumes and increased throughput for a range of ADME-Tox assays
  • Intuitive software applications to multiplex assays and dose-response conditions
  • Walk-up automation with the benefits of Echo liquid handling technology
  • Minimal training requirements
WEBINAR
A New Approach to Early ADME CYP450 Inhibition Profiling Using the Echo® Liquid Handler
Jing Wang - ADME Tox Webinar
Jing Wang    |   Applications Scientist, Labcyte Inc.
The high cost of drug discovery and the frequent failure of compounds due to poor ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) properties necessitate an earlier study of ADMET profiles...